Compare Agilent Technologies Inc (A) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs JPMorgan Equity Premium Income ETF — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while JPMorgan Equity Premium Income ETF trades at $56.54. The key difference: Agilent Technologies Inc pays a 0.78% dividend while JPMorgan Equity Premium Income ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| A | JEPI | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $157.20 | $59.88 |
52-Week Low | $110.24 | $55.29 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
JEPI trades at $56.75, up 0.07% on the day, with a bullish technical signal from moving averages. The ETF's covered-call strategy generates an 8%+ yield, providing income but capping upside potential. Recent news highlights its role as a low-volatility hedge amid muted S&P 500 volatility, though tax efficiency comparisons with peers like SPYI are a focus.
The outlook for JEPI centers on income generation in flat or declining markets, with risks including underperformance in strong bull runs and tax implications on distributions. Its active management offers resilience, but total return may lag the broader market over time.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
